Immunotherapy

Skin immunization for effective treatment of multifocal melanoma refractory to PD1 blockade and Braf inhibitors
Xingxing Hao, Louis D Falo III, Guo Chen, Jiying Zhang, Cara D Carey, Walter J Storkus, Louis D Falo Jr, Zhaoyang You

Journal for ImmunoTherapy of Cancer Jan 2021, 9 (1) e001179; DOI: 10.1136/jitc-2020-001179
Blockade of AIM2 inflammasome or α1-AR ameliorates IL-1β release and macrophage-mediated immunosuppression induced by CAR-T treatment
Dan Liu, Xiyue Xu, Yulian Dai, Xuan Zhao, Shunshun Bao, Wen Ma, Li Zha, Shuci Liu, Yuchen Liu, Junnian Zheng, Ming Shi

Journal for ImmunoTherapy of Cancer Jan 2021, 9 (1) e001466; DOI: 10.1136/jitc-2020-001466
Letter to the editor: Checking the pulse of adoptive cell therapy for solid tumors. Thoughts from the abstracts submitted to the 35th Annual Meeting of the Society for the Immunotherapy of Cancer (SITC 2020)
Martina Markovska, Francesco Marincola

Journal for ImmunoTherapy of Cancer Jan 2021, 9 (1) e002216; DOI: 10.1136/jitc-2020-002216
Use of plasma ctDNA as a potential biomarker for longitudinal monitoring of a patient with metastatic high-risk upper tract urothelial carcinoma receiving pembrolizumab and personalized neoepitope-derived multipeptide vaccinations: a case report
Carolin Blumendeller, Julius Boehme, Maximilian Frick, Martin Schulze, Antje Rinckleb, Christina Kyzirakos, Simone Kayser, Maria Kopp, Sabine Kelkenberg, Natalia Pieper, Oliver Bartsch, Dirk Hadaschick, Florian Battke, Arnulf Stenzl, Saskia Biskup

Journal for ImmunoTherapy of Cancer Jan 2021, 9 (1) e001406; DOI: 10.1136/jitc-2020-001406
Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future
Razan Alzeibak, Tatiana A. Mishchenko, Natalia Y. Shilyagina, Irina V. Balalaeva, Maria V. Vedunova, Dmitri V. Krysko

Journal for ImmunoTherapy of Cancer Jan 2021, 9 (1) e001926; DOI: 10.1136/jitc-2020-001926
Fecal calprotectin concentration to assess endoscopic and histologic remission in patients with cancer with immune-mediated diarrhea and colitis
Fangwen Zou, Xuemei Wang, Isabella C Glitza Oliva, Jennifer L McQuade, Jennifer Wang, Hao Chi Zhang, John A Thompson, Anusha S Thomas, Yinghong Wang

Journal for ImmunoTherapy of Cancer Jan 2021, 9 (1) e002058; DOI: 10.1136/jitc-2020-002058
Incidence of thromboembolism in patients with melanoma on immune checkpoint inhibitor therapy and its adverse association with survival
Tamara A Sussman, Hong Li, Brian Hobbs, Pauline Funchain, Keith R McCrae, Alok A Khorana

Journal for ImmunoTherapy of Cancer Jan 2021, 9 (1) e001719; DOI: 10.1136/jitc-2020-001719
Therapy of lymphoma by immune checkpoint inhibitors: the role of T cells, NK cells and cytokine-induced tumor senescence
Fatima Ahmetlic, Josia Fauser, Tanja Riedel, Vera Bauer, Carolin Flessner, Nadine Hömberg, Roman Hennel, Ellen Brenner, Kirsten Lauber, Martin Röcken, Ralph Mocikat

Journal for ImmunoTherapy of Cancer Jan 2021, 9 (1) e001660; DOI: 10.1136/jitc-2020-001660
Deletion of Cbl-b inhibits CD8⁺ T-cell exhaustion and promotes CAR T-cell function
Jitendra Kumar, Ritesh Kumar, Amir Kumar Singh, Elviche L Tsakem, Mahesh Kathania, Matthew J Riese, Arianne L Theiss, Marco L Davila, K Venuprasad

Journal for ImmunoTherapy of Cancer Jan 2021, 9 (1) e001688; DOI: 10.1136/jitc-2020-001688
Estrogen receptor beta signaling in CD8⁺ T cells boosts T cell receptor activation and antitumor immunity through a phosphotyrosine switch
Bin Yuan, Curtis A Clark, Bogang Wu, Jing Yang, Justin M Drerup, Tianbao Li, Victor X Jin, Yanfen Hu, Tyler J Curiel, Rong Li

Journal for ImmunoTherapy of Cancer Jan 2021, 9 (1) e001932; DOI: 10.1136/jitc-2020-001932

Main menu

Immunotherapy

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Immunotherapy

Pages